H.C. Wainwright Downgrades FibroGen (FGEN) to Neutral
Tweet
Share
E-mailGet Alerts FGEN Hot Sheet
Price: $9.71 --0%
Rating Summary:
4 Buy, 8 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 23
Rating Summary:
4 Buy, 8 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 23
Join SI Premium – FREE
H.C. Wainwright analyst Edwin Zhang downgraded FibroGen (NASDAQ: FGEN) from Buy to Neutral.
For an analyst ratings summary and ratings history on FibroGen click here. For more ratings news on FibroGen click here.
Shares of FibroGen closed at $25.90 yesterday.
You May Also Be Interested In
- Nomura/Instinet Downgrades China Literature (772:HK) (CHLLF) to Neutral
- BNP Paribas Exane Downgrades Lanxess AG (LXS:GR) (LNXSF) to Underperform
- Baird Downgrades Ramaco Resources Inc. (METC) to Neutral
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
